Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,075.00    -515.00 (-9.21%)
Bid:
5,060.00
Ask:
5,065.00
Spread: 5.00 (0.099%)
Market Cap: $1.33t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Spin-off Completion Report

4 Nov 2016 09:05

RNS Number : 3614O
Samsung Electronics Co. Ld
04 November 2016
 

Spin-off Completion Report

 

. Timeline

 

Event

Date

Resolution of Board of Directors

09/12/2016

Issue of Spin-off report

09/12/2016

Submission of Decision on Spin-off Report

09/12/2016

Finalizing the shareholder list

09/28/2016

Closure of Share transfer book

Start date

09/29/2016

End date

10/04/2016

Extraordinary General Meeting of Shareholders

for the approval of Spin-off report

10/27/2016

Spin-off

11/01/2016

General assembly of corporate division report and inaugural meeting

11/02/2016

Spin-off registration

11/04/2016

(Note) The general assembly of corporate division report or inaugural meeting provided above was replaced

with the notice and resolution of Board of Directors.

 

. Change in stock or ratio of shares owned by major shareholders

Not applicable as this transaction constitutes a straight spin-off

 

. Appraisal rights of shareholders

Not applicable as this transaction constitutes a straight spin-off

 

. Protection of creditors

According to Paragraph 1 of Article 530-9 of the Commercial Act, Samsung Electronics Co., Ltd.

(hereinafter referred to as "the Company"), and S-Printing Solution Co., Ltd. (hereinafter referred to

as "the New Corp.") shall be jointly liable for liabilities of the Company that existed prior to spin-off.

 

. Relevant lawsuits

As of the date of this report, no lawsuits that can affect the validity of the spin-off have been filed.

 

. New shares allotment

As this transaction constitutes a straight spin-off, 100% of the shares issued by the New Corp were

allotted to the Company.

 

. Pre/Post Spin-Off Financial Position

Pre/Post Spin-Off Financial Position (June 30, 2016)

 

(Unit:KRW million)

Item

Pre spin-off

Post spin-off

Surviving entity

New entity

I. Assets

163,313,133

163,103,998

347,658

1. Current assets

65,317,792

65,070,212

247,580

2. Non-current assets

97,995,341

98,033,786

100,077

II. Liabilities

30,303,810

30,094,675

209,135

1. Current liabilities

26,742,315

26,613,443

128,872

2. Non-current liabilities

3,561,495

3,481,232

80,263

III. Equity

133,009,323

133,009,323

138,523

1. Equities

897,514

897,514

50,000

2. Share premium

4,403,893

4,403,893

88,523

3. Retained earnings

138,556,832

138,556,832

- 

4. Other components of equity

-10,848,916

-10,848,916

- 

(Note) The above figures are based on the financial position as of June 30, 2016 and can be adjusted in

accordance with business circumstances by the date of spin-off.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKZLBBQFFBFBL
Date   Source Headline
1st Jun 20268:51 amRNSCorporate Governance Report FY2025
29th May 20269:45 amRNS2026 1Q Interim Business Report
30th Apr 20269:03 amRNS2025 Business Report
30th Apr 20268:51 amRNSTransaction with Affiliate Company
30th Apr 20267:49 amRNSQuarterly Dividend for First Quarter 2026
30th Apr 20267:47 amRNS2026 1Q Earnings Release
24th Apr 20269:30 amRNSReport on Share Repurchase Results
7th Apr 20268:31 amRNSNotice of 1Q 2026 Earnings Release Schedule
7th Apr 20268:31 amRNS1Q 2026 Pre-Earnings Guidance
31st Mar 20268:32 amRNSDecision on Cancellation of Shares
25th Mar 20268:28 amRNSReport on Share Disposition Results
19th Mar 20267:46 amRNSSamsung Electronics Corporate Value Enhancement
18th Mar 20268:38 amRNSCharitable Contribution
18th Mar 20268:28 amRNSDecision on Share Disposition
18th Mar 20268:28 amRNSDecision on Share Repurchase
18th Mar 20268:28 amRNSResults of the 57th Annual General Meeting
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:47 amRNSReport on Share Repurchase Results
12th Mar 20267:47 amRNSReport on Share Repurchase Results
25th Feb 20267:00 amRNSReplacement of Reference Material for 2026 AGM
13th Feb 20267:44 amRNSCharitable Contributions
13th Feb 20267:43 amRNSReference Material for 2026 AMG
12th Feb 202610:04 amRNS2025 Consolidated Financial Statements
12th Feb 202610:03 amRNS2025 Separate Financial Statements
4th Feb 20268:50 amRNSReport on Share Disposition Results
29th Jan 20268:25 amRNSReport on Share Disposition Results
29th Jan 20268:24 amRNSDecision on Share Disposition
29th Jan 20268:23 amRNSDecision on Share Repurchase
29th Jan 20267:52 amRNS2025 Capex Results
29th Jan 20267:52 amRNSYear-End Dividend for FY2025
29th Jan 20267:00 amRNS2025 4Q Earnings Release
27th Jan 20268:20 amRNSReport on Share Repurchase Results
26th Jan 20267:00 amRNSDecision on Share Disposition
8th Jan 20268:23 amRNSNotice of 4Q 2025 Earnings Release Schedule
8th Jan 20268:23 amRNS4Q 2025 Pre-Earnings Guidance
7th Jan 202610:28 amRNSDecision on Share Repurchase
28th Nov 20258:32 amRNS2025 3Q Interim Business Report
28th Nov 20258:29 amRNSTransaction with Affiliate Company
28th Nov 20258:27 amRNSAppointment of New Chief Executive Officer
28th Nov 20258:27 amRNSCharitable Contribution
5th Nov 20258:19 amRNSReport on Share Disposition Results
30th Oct 20258:16 amRNSDecision on Share Disposition
30th Oct 20257:58 amRNSCharitable Contribution
30th Oct 20257:58 amRNSAnnouncement of Capex Plan for FY 2025
30th Oct 20257:56 amRNSQuarterly Dividend for Third Quarter 2025
30th Oct 20257:00 amRNS2025 3Q Earnings Release
14th Oct 20258:44 amRNSNotice of 3Q 2025 Earnings Release Schedule
14th Oct 20258:42 amRNS3Q 2025 Pre-Earnings Guidance
2nd Oct 20259:02 amRNSReport on Share Repurchase Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.